Good morning. We open on a number the regulator put on paper this week: 700%. That is the mark-up some cancer medicines pick up between the trade and your patient, and it is the reason India moved on Thursday. Three more stories below, and one of them is about your chai.
— DR. ADITYA SETH, EDITOR-IN-CHIEF
01 · THE LEAD
PHARMA
India caps cancer drug trade margins at 30%. Nobody knows which drugs yet.
Data placed before the National Pharmaceutical Pricing Authority showed cancer medicines outside price control carrying an average trade mark-up of around 170%, reaching 700% in some cases. Strip the percentages out and a strip that cost the trade ₹100 is handed across the counter at ₹800. At its 283rd meeting on Thursday the authority approved, in principle, a cap on trade margins at 30% of MRP for identified non-scheduled anti-cancer medicines.
Almost all of oncology sits on that unprotected track: roughly 225 drugs and 500 formulations worth about ₹12,500 crore a year, of which scheduled medicines account for only ₹2,250 crore. Printed prices on covered drugs are expected to fall by 20% to 70%. Nothing moves at the chemist's counter, though, until a DGHS expert committee names them, and that report is due on 14 October.
WHY IT MATTERS
Your patient's bill falls only if their molecule makes the list, and the list is four days away.
It went through Paragraph 19 of the DPCO, the public-interest clause, so a drug does not have to be on the essential medicines list to be covered.
The same lever ran in 2019 across 42 drugs and cut MRPs by up to 91%, so the mechanism has a track record.
02 · PHARMA
An Iron-folic acid batch assayed at 62% of its folic acid. The pharmacopoeial floor is 90%.
Iron and folic acid is close to reflex in Indian practice. You write it for anaemia and through pregnancy, the patient takes it for months, and nobody goes back to check whether it worked. A Palghar-made batch with about a year still left on the shelf turned up on CDSCO's August Not of Standard Quality list carrying, in plain terms, the folic acid of roughly six tablets in every ten. The batch number is worth writing down before your next antenatal clinic.
03 · RESEARCH
Very hot drinkers carried three times the squamous cell risk. The sixth glass had a risk of its own.
Oxford Population Health pooled 977,282 adults from the Million Women Study and UK Biobank and followed them for more than a decade. People who said they took their tea and coffee very hot carried 3.17 times the risk of oesophageal squamous cell carcinoma of those who took them warm, with cups per day already accounted for. Adenocarcinoma did not move at all. Then the team ran frequency on its own, holding temperature constant, and six or more drinks a day still carried a 71% higher squamous cell risk. Letting the glass cool did not cancel reaching for the next one. India has been running a version of this experiment for fifty years, and the one valley where it is documented drinks a tea that is chemically unlike anyone else's.
04 · EXAMS AND ADMISSIONS
Free MD/MS OBG ran out at rank 9,714. Paid seats went on to 78,674.
Every MD/MS Obstetrics and Gynaecology seat MCC gave out in Round 1 between 2023 and 2025, all 4,749 of them, sorted by what each rank and each category actually got. Half the open seats were gone by rank 4,168. At rank 1,000 an open candidate could still reach 157 colleges; at 7,500, twenty-five. And in the stretch from 9,715 to 25,000, where the free All India Quota list runs dry, there were 236 open DNB seats that most counselling advice never gets to.
05 · HEALTH TECH
|
Health Tech
|
Utah cleared an app to write a first prescription. Two doctors check every one, for now.
About one acne patient in ten in Utah ever sees a dermatologist, and the average wait for that appointment runs to 61 days ( Imagine your value if same amount of time a patient has to wait to see you). The waiting list is why this got through. An adult in the state can now photograph their face from five angles, answer a short questionnaire, and have a treatment plan back inside the quarter hour, with a prescription if they qualify. No appointment, and nobody waiting at the other end of it. Acne only, adults only, Utah only. Two licensed physicians approve every prescription independently for the first 100 patients, and the checking gets lighter once they agree with the machine at least 95% of the time. The state’s own licensing board had asked for the previous AI prescribing programme to be suspended, and never got an answer.
06 · QUICK HITS
What did you think of today's email?
Built by doctors. Read by doctors.
Know a colleague who should be reading this? Forward this email to them.
Forwarded this issue? Subscribe free →